Rubicon Holdings

Rubicon Research is a leading specialty pharmaceutical company focused on developing and manufacturing high-quality, value-added generic and specialty products. The company leverages its proprietary drug delivery technology platforms to create innovative formulations that improve patient compliance and therapeutic outcomes. With a robust portfolio spanning multiple therapeutic areas such as pain management and cardiovascular health, Rubicon operates state-of-the-art R&D and manufacturing facilities that comply with global regulatory standards. The company serves as a strategic partner to global pharmaceutical firms, providing end-to-end solutions from product development to commercial supply.